¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"maximal tubular excretory capacity"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • excretory urography
    ¹è¼³¿ä·ÎÁ¶¿µ(¼ú)
  • excretory-secretory antigen
    ¹è¼³ºÐºñÇ׿ø
  • maximal afterloaded contraction
    ÃÖ´ëÈĺÎÇϼöÃà
  • maximal diastolic potential
    ÃÖ´ëÀ̿ϱâÀüÀ§
  • maximal expiratory flow
    Ãִ볯¼ûÀ¯·®, ÃÖ´ëÈ£±â·®
  • maximal expiratory level
    Ãִ볯¼û¼öÁØ, ÃÖ´ëÈ£±â°ª
  • maximal growth rate
    ÃÖ´ëÁõ½Ä·ü, Ãִ뼺Àå·ü
  • maximal inspiratory level
    ÃÖ´ëµé¼û¼öÁØ, ÃÖ´ëÈí±â°ª
  • maximal midexpiratory flow rate
    ÃÖ°íÁß°£³¯¼ûÀ¯¼Ó, ÃÖ°íÁß°£È£±âÀ¯¼Ó
  • maximal stimulus
    ÃÖ´ëÀÚ±Ø
  • maximal volition period
    ÃÖ´ë¼öÃà±â
  • antigen binding capacity
    Ç׿ø°áÇÕ´É
  • adsorption capacity
    ÈíÂø´É
  • agglutinating capacity
    ÀÀÁý´É
  • bladder capacity
    ¹æ±¤¿ëÀû
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • total iron binding capacity
    ÃÑö°áÇÕ´É
  • total lung capacity
    ÃÑÆó¿ë·®, ¿ÂÇãÆÄ¿ë·®
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • maximal expiratory level
    Ãִ볯¼û¼öÁØ
  • maximal inspiratory level
    ÃÖ´ëµé¼û¼öÁØ
  • maximal stimulus
    ÃÖ´ëÀÚ±Ø
  • maximal conduction velocity
    ÃÖ´ëÀüµµ¼Óµµ
  • maximal diastolic potential
    ÃÖ´ëÀ̿ϱâÀüÀ§
  • maximal growth rate
    ÃÖ´ëÁõ½Ä·ü
  • maximal midexpiratory flow rate
    ÃÖ´ëÁß°£³¯¼ûÀ¯¼Ó
  • maximal stimulation test
    ÃÖ´ëÀڱذ˻ç
  • maximal voiding rate
    ÃÖ´ë¹è´¢À²
  • maximal volition period
    ÃÖ´ë¼öÃà±â
  • maximal voluntary ventilation
    ÃÖ´ë³ë·ÂÈ£Èí, ÃÖ´ë¼öÀÇȯ±â·®
  • renal tubular acidosis
    ÄáÆÏ´¢¼¼°ü»êÁõ
  • tubular adenoma
    ´ë·Õ»ùÁ¾
  • tubular bronchiectasis
    °ü¸ð¾ç±â°üÁöÈ®ÀåÁõ
  • tubular carcinoma
    °ü¾ÏÁ¾
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • VC= vital capacity
    ÆóȰ·®, Æó¸ð¼¼°ü Ç÷¾×·®.
  • adsorption capacity
    ÈíÂø´É(ýåó·Òö).
  • agglutinating capacity
    ÀÀÁý´É
  • antigen binding capacity
    Ç׿ø°áÇÕ´É(¡­Ì¿ùêÒö).
  • functional residual capacity =FRC
    ±â´ÉÀû ÀÜ·ù¿ë·®(íÑ×¶éÄÕá), ±â´ÉÀû Àܱⷮ(íÑѨÕá).
  • heat capacity
    ¿­¿ë·®(æðé»åÖ).
  • inspiratory capacity
    Èí½Ä¿ë·®, Èí±â¿ëÀû.
  • inspiratory capacity
    Èí½Ä¿ë·®(ýåãÓé»Õá), Èí±â¿ëÀû(ýåѨé»îÝ) .
  • inspiratory capacity
    Èí½Ä¿ë·®,Èí±â¿ëÀû
  • inspiratory vital capacity
    Èí±âÆóȰ·®(ýåѨøËüÀÕá).
  • inspiratory vital capacity
    Èí±âÆóȰ·®.
  • predicted vital capacity
    ¿¹ÃøÆóȰ·®(çãö´øËüÀåÖ).
  • pulmonary diffusing capacity
    ÆóÈ®»ê´É(·Â)(øËüªß¤Òöæ³).
  • pulmonary ventilatory capacity
    Æóȯ±â¿ë·®.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • maximal blood pressure
    ÃÖ´ëÇ÷¾Ð(õÌÓÞúìäâ), ÃÖ°íÇ÷¾Ð(õÌÍÔúìäâ).
  • maximal clearance
    ÃÖ´ëŬ¸®¾î·±½º, ±Ø<ÃÖ>´ëû¼Ò¿ëÀû(п<õÌ>
  • maximal diastolic potential
    ÃÖ´ëÀ̿ϱâÀü¾Ð(õÌÓÞì¬èÐÑ¢ï³äâ)
  • maximal diffusing
    ÃÖ´ëÈ®»ê(õÌÓÞüªß¤).
  • maximal dose
    ÃÖ´ë¿ë·®(õÌÓÞéÄåÖ).
  • maximal effective dose
    ÃÖ´ëÀ¯È¿·®(õÌÓÞêóüùåÖ).
  • maximal ejection phase
    Ãִ뱸Ãâ±â(¡­ÏÌõóÑ¢).
  • maximal expiratory flow =MEF
    ÃÖ´ëÈ£±â·®(¡­û¼Ñ¨åÖ).
  • maximal expiratory level
    ÃÖ´ëÈ£±âÀ§(¡­û¼Ñ¨êÈ).
  • maximal growth rate
    ÃÖ´ëÁõ½ÄÀ²
  • maximal inspiratory level
    ÃÖ´ëÈí±âÀ§(¡­ýåѨêÈ).
  • maximal midexpiratory flow
    ÃÖ´ëÈ£±âÁß°£À¯ ·®(¡­û¼Ñ¨ñéÊàêüåÖ).
  • maximal stimulus
    ÃÖ´ëÀÚ±Ø(¡­ô§Ð½).
  • maximal surgical blood order schedule=MSBOS
    ÃÖ´ë¼ö¼úÇ÷¾×½Åû·®
  • maximal temperature
    ±Ø´ë¿Âµµ(пÓÞè®öô).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MVV   1) Maximal Voluntary Volume
    = MBV
  2) Maximal V...
MES maintenance electrolyte solution; maximal electroshock; maximal electroshock seizures; myoelectric s...
MRE maximal resistive exercise; maximal respiratory effectiveness
PMI pain management inventory; past medical illness; patient medication instruction; perioperative myoca...
MBC   1) Maximal Breathing Capacity
  2) Minimal Bactericidal Concentration
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ES Excretory-secretory products
ESA excretory-secretory antigen
ATN Acute Tubular Necrosis
TBM Anti-tubular basement membrane
DRTA Distal renal tubular acidosis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • tubular trabecular
    µµ°ü»ó
  • agglutinating capacity
    ÀÀÁý´É
  • capacity coefficient
    ¿ë·® °è¼ö
  • cranial capacity
    µÎ°³³» ¿ë·®
  • diffusing capacity
    È®»ê´É, È®»ê¼º ´É·Â
    ÆóÀå¿¡ À־ °¡½º È®»ê´ÉÀ̶õ 1ºÐ µ¿¾È¿¡ 1 mmHgÀÇ ¾Ð·ÂÂ÷°¡ ÀÖÀ» ¶§ Àüü ÆóÆ÷ º®À» ÅëÇØ¼­ À̵¿ÇÏ´Â °¡½ºÀÇ ¾çÀÌ´Ù.
  • expiratory vital capacity
    È£½Ä ÆóȰ·®
  • forced vital capacity
    °­Á¦ ÆÐȰ·®, ³ë·Â¼º ÆóȰ·®, ³ë¼º ÆóȰ·®
  • functional residual capacity
    ±â´ÉÀû ÀÜ·ù ¿ë·®, ±â´ÉÀû Àܱⷮ
  • heat capacity
    ¿­ ¿ë·®
    ¾î¶² ¹°Ã¼ÀÇ ¿Âµµ¸¦ 1 ¡É ³ôÀÌ´Â µ¥ ÇÊ¿äÇÑ ¿­·®. ¹°Ã¼ÀÇ ¿Âµµ°¡ ¾ó¸¶³ª ½±°Ô º¯ÇÏ´À³Ä¸¦ ³ªÅ¸³»´Â ¾çÀ¸·Î¼­ °¡·É ¿­ ¿ë·®ÀÌ Å« ¹°Ã¼´Â ¿Âµµ°¡ Àß º¯ÇÏÁö ¾Ê´Â ¹Ý¸é ¿­ ¿ë·®ÀÌ ÀÛÀº ¹°Ã¼´Â Á¶±Ý¸¸ ¿­À» °¡°¨Çصµ ½±°Ô ¿Âµµ º¯È­¸¦ ÀÏÀ¸Å°°Ô µÈ´Ù. ±× °ªÀº Áú·®¿¡ ºñ·ÊÇϸç, ´ÜÀ§ Áú·®ÀÇ ¿­ ¿ë·®Àº °¢ ¹°Áú °íÀ¯ÀÇ °ªÀ¸·Î ³ªÅ¸³ª´Âµ¥, À̰ÍÀ» ±× ¹°ÁúÀÇ ºñ¿­À̶ó°í ÇÑ´Ù. Áï ¾î¶² ¹°Ã¼ÀÇ ¿­ ¿ë·®Àº ºñ¿­°ú Áú·®À» °öÇÑ °ÍÀ̶ó ÇÒ ¼ö ÀÖ´Ù.
  • leukocyte bactericidal capacity test
    ¹éÇ÷±¸ »ì±Õ·Â °Ë»ç¹ý
  • lung capacity
    ÆÐ ¿ë·®
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
point of maximal impulse The point on the chest wall at which the maximal cardiac impulse is seen and/or felt.
(05 Mar 2000)
acute tubular necrosis <nephrology> A kidney disorder that results in damage to the renal tubule cells leading to acute renal failure. Acute tubular necrosis can result from any condition which deprives the kidney of oxygen (ischaemia).
Acute tubular necrosis may occur as a complication of shock, trauma or sepsis. Conditions such as diabetes or liver disease can predispose people to the development of acute tubular necrosis. Certain medications (for example aminoglycosides, amphotericin B, cyclosporine) are known to cause acute tubular necrosis as a toxic side effect. Radiopaque contrast dyes, used in some radiologic procedures, may also result in acute tubular necrosis as a rare complication from contrast dye use.
Acronym: ATN
(13 Nov 1997)
renal tubular acidosis <nephrology> A rare sometimes familial disorder of the renal tubule characterised by the inability to excrete urine of normal acidity.
This leads to a hyperchloraemic acidosis which is often associated with one or more secondary complications such as hypercalcinuria with nephrolithiasis and nephrocalcinosis, rickets, or osteomalacia and severe potassium depletion.
(25 Jun 1999)
renal tubular transport, inborn errors Genetically determined disorders of the reabsorptive functions of the kidney with regard to specific nephron segments responsible for specific transport functions, classifiable by proximal nephron function, loop of henle function, and distal nephron function. The transport defects can be selective or nonselective.
(12 Dec 1998)
Pick's tubular adenoma A neoplasm of the ovary, arising from the ovarian stroma, mimicking to a greater or lesser extent derivatives of the sex cord mesenchyme of the testis, and sometimes causing defeminization and virilization.
(12 Dec 1998)
primary renal tubular acidosis A metabolic defect in the mechanism of urinary acidification that may be either the transient type, with onset in infancy, or the persistent type, with onset in childhood or adult years; both types are familial.
(05 Mar 2000)
secondary renal tubular acidosis Renal tubular acidosis that may occur as a complication of hypercalcaemic states, hyperglobulinaemic disorders, and in some other chronic renal conditions; a regular component of De Toni-Fanconi syndrome.
(05 Mar 2000)
osteopetrosis with renal tubular acidosis <syndrome> An inherited deficiency of carbonic anhydrase II that results in osteopetrosis and metabolic acidosis.
Synonym: osteopetrosis with renal tubular acidosis.
(05 Mar 2000)
ovarian tubular adenoma <oncology, tumour> A type of ovarian tumour whose sells secrete a male sex hormone (testosterone) causing virilisation in women.
(27 Sep 1997)
testicular tubular adenoma A neoplasm of the ovary, arising from the ovarian stroma, mimicking to a greater or lesser extent derivatives of the sex cord mesenchyme of the testis, and sometimes causing defeminization and virilization.
(12 Dec 1998)
tubular <anatomy> Shaped like a tube, of or pertaining to a tubule.
Origin: L. Tubularis
(18 Nov 1997)
tubular adenoma <tumour> A benign neoplasm composed of epithelial tissue resembling a tubular gland.
(05 Mar 2000)
tubular aneurysm The uniform dilation of an artery along a considerable distance.
Synonym: cylindroid aneurysm.
(05 Mar 2000)
tubular carcinoma <tumour> A well-differentiated form of ductal breast carcinoma with invasion of the stroma by small epithelial tubules.
(05 Mar 2000)
tubular cyst A cyst formed by the dilation of any occluded canal or tube.
Synonym: tubular cyst.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á